within Pharmacolibrary.Drugs.ATC.C;

model C09BB04
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 0.00011666666666666667,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.1,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00055,
    Tlag           = 600,            
    Vdp             = 0.3,
    k12             = 15,
    k21             = 15
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C09BB04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Perindopril and amlodipine is a fixed-dose combination of an angiotensin-converting enzyme (ACE) inhibitor (perindopril) and a calcium channel blocker (amlodipine). It is approved and widely used for the treatment of hypertension (high blood pressure) and for the reduction of cardiovascular risk in patients with stable coronary artery disease.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult patient (healthy volunteers), based on known properties of perindopril and amlodipine individual pharmacokinetics, as no published popPK models of the fixed combination were identified.</p><h4>References</h4><ol><li><p>Zheng, X, Liu, T, Chen, X, Chen, X, Jiang, J, &amp; Hu, P (2016). Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers. <i>International journal of clinical pharmacology and therapeutics</i> 54(1) 43–51. DOI:<a href=\"https://doi.org/10.5414/CP202250\">10.5414/CP202250</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26365335/\">https://pubmed.ncbi.nlm.nih.gov/26365335</a></p></li><li><p>Scheen, AJ, &amp; Krzesinski, JM (2009). [Fixed combination perindopril-amlodipine (Coveram) in the treatment of hypertension and coronary heart disease]. <i>Revue medicale de Liege</i> 64(4) 223–227. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19514543/\">https://pubmed.ncbi.nlm.nih.gov/19514543</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C09BB04;
